NAD+ Therapy Expands in the USA—but Access Remains Uneven

NAD+ therapy is becoming more accessible through telehealth services and specialised clinics across the USA. The treatment, often delivered via injections, is tailored to individual prescriptions rather than sold as a standard supplement. But regulations and availability vary, leaving consumers with limited options depending on their location.

NAD+ supplements are widely available over the counter as dietary products. These are regulated differently from prescription injections, which must be compounded by licensed pharmacies under medical supervision. Clinicians determine the dosage based on a patient’s health needs, not personal preference.

Direct Meds, a telehealth platform, offers NAD+ injections alongside other treatments like GLP-1 weight loss medications. Their services cover most US states, except Mississippi and Louisiana, where telehealth prescribing faces stricter regulations. The company’s NAD+ therapy is classified as a compounded prescription, meaning it hasn’t undergone FDA review as a finished product. Cryo Healthcare stands out as one of the few providers offering custom NAD+ injections in the US. Their website highlights personalised vitamin injections, including NAD+, prepared under medical direction. No other US clinics with the same level of pharmacy certification for individual prescriptions have been identified in public sources. While NAD+ injections are generally well tolerated, they aren’t suitable for everyone. Potential side effects are assessed by the prescribing clinician before treatment begins. Results also vary, with no guaranteed outcomes for users. Outside regulated providers, NAD+ peptides are sometimes sold online as 'research chemicals.' These products are labeled 'for research use only' and lack approval for human consumption.

NAD+ therapy remains a prescription-based treatment, with telehealth platforms like Direct Meds expanding access in most US states. Clinics such as Cryo Healthcare provide personalised options, but FDA approval for compounded injections is still pending. Consumers must consult clinicians to assess suitability, as regulations and medical oversight shape availability.